Folic acid-modified Prussian blue/polydopamine nanoparticles as an MRI agent for use in targeted chemo/photothermal therapy-Reference-Cited by-同舟云学术

Folic acid-modified Prussian blue/polydopamine nanoparticles as an MRI agent for use in targeted chemo/photothermal therapy

Published:2019 Issue:7 Volume:7 Page:2996-3006
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Lin Xiao¹²³⁴⁵,Cao Yanbin¹²³⁴⁵,Li Jiong⁶⁷⁸⁹,Zheng Dongye⁶⁷⁸⁹,Lan Shanyou⁶⁷⁸⁹,Xue Yanan¹²³⁴⁵,Yu Faquan¹²³⁴⁵^ORCID,Wu Ming⁶⁷⁸⁹^ORCID,Zhu Xunjin¹⁰¹¹¹²¹³¹⁴^ORCID

Affiliation:

1. Key Laboratory for Green Chemical Process of Ministry of Education

2. Hubei Key Laboratory for Novel Reactor and Green Chemistry Technology

3. Hubei Engineering Research Center for Advanced Fine Chemicals

4. School of Chemical Engineering and Pharmacy

5. Wuhan Institute of Technology

6. The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province

7. Mengchao Hepatobiliary Hospital of Fujian Medical University

8. Fuzhou 350025

9. P. R. China

10. Department of Chemistry and State Key Laboratory of Environmental and Biological Analysis

11. Hong Kong Baptist University

12. Kowloon Tong

13. Hong Kong

14. P.R. China

Abstract

A versatile nanotheranostic agent of PB@PDA@PEG-FA-DOX was fabricated for active-targeting and MRI-guided combinatorial chemo/photothermal therapy for cancer.

Funder

National Natural Science Foundation of China

Hong Kong Baptist University

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2019/BM/C9BM00276F

Reference47 articles.

1. Chemotherapy counteracted

2. Cancer: Reshaping the cancer clinic